Breaking News
Get 55% Off 0
🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% each
Unlock Stocks

Stock Markets Analysis & Opinion

Contribute
Edison
Orexigen Therapeutics: Contrave Outperforming   By Edison - Aug 17, 2017

Orexigen Therapeutics' (NASDAQ:OREX) re-launch of Contrave continues to be successful, with an 18% increase in prescriptions in the United States in Q217 compared to Q117. Importantly, net revenue per...

Continue with Apple
Continue with Google
or
Sign up with Email